Free Trial
NASDAQ:BDRX

Biodexa Pharmaceuticals (BDRX) Stock Price, News & Analysis

Biodexa Pharmaceuticals logo
$0.87 -0.01 (-1.59%)
Closing price 03:26 PM Eastern
Extended Trading
$0.87 0.00 (0.00%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Biodexa Pharmaceuticals Stock (NASDAQ:BDRX)

Key Stats

Today's Range
$0.85
$0.89
50-Day Range
$0.80
$1.55
52-Week Range
$0.78
$41.50
Volume
77,527 shs
Average Volume
1.10 million shs
Market Capitalization
$31.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biodexa Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

BDRX MarketRank™: 

Biodexa Pharmaceuticals scored higher than 12% of companies evaluated by MarketBeat, and ranked 2656th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Biodexa Pharmaceuticals.

  • Earnings Growth

    Earnings for Biodexa Pharmaceuticals are expected to remain at ($1.25) per share in the coming year.

  • Price to Book Value per Share Ratio

    Biodexa Pharmaceuticals has a P/B Ratio of 2.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Biodexa Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    0.49% of the float of Biodexa Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Biodexa Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biodexa Pharmaceuticals has recently decreased by 51.49%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Biodexa Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Biodexa Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.49% of the float of Biodexa Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Biodexa Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biodexa Pharmaceuticals has recently decreased by 51.49%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Biodexa Pharmaceuticals has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Biodexa Pharmaceuticals this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Biodexa Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.34% of the stock of Biodexa Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 17.51% of the stock of Biodexa Pharmaceuticals is held by institutions.

  • Read more about Biodexa Pharmaceuticals' insider trading history.
Receive BDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BDRX Stock News Headlines

How to Collect Up To $5,917/mo From Trump’s Made In USA Boom
How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback.
Results of Annual General Meeting
Biodexa Pharmaceuticals Plc (BDRX) - Yahoo Finance
See More Headlines

BDRX Stock Analysis - Frequently Asked Questions

Biodexa Pharmaceuticals' stock was trading at $4.05 at the beginning of the year. Since then, BDRX stock has decreased by 78.6% and is now trading at $0.8660.

Biodexa Pharmaceuticals PLC Unsponsored ADR (NASDAQ:BDRX) announced its quarterly earnings results on Thursday, September, 10th. The company reported ($1,600.00) EPS for the quarter.

Biodexa Pharmaceuticals's stock reverse split on Friday, October 4th 2024.The 1-25 reverse split was announced on Thursday, September 19th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of BDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biodexa Pharmaceuticals investors own include SoundHound AI (SOUN), Dyne Therapeutics (DYN), NVIDIA (NVDA), Viking Therapeutics (VKTX), TRACON Pharmaceuticals (TCON), ASE Technology (ASX) and BigBear.ai (BBAI).

Company Calendar

Last Earnings
9/10/2020
Today
7/03/2025
Next Earnings (Estimated)
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BDRX
Previous Symbol
LON:MTPH
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$470 thousand
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
2.99

Miscellaneous

Free Float
36,420,000
Market Cap
$31.64 million
Optionable
Not Optionable
Beta
1.17
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:BDRX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners